BELLMAWR, N.J.--(BUSINESS WIRE)--Curaleaf, a provider of high-quality, reliable and safe cannabinoid-based products, officially opened a new dispensary across the street from its current Bellmawr location, formerly known as Compassionate Sciences Alternative Treatment Center. Following a gradual rebranding process, existing patients – as well as new patients who qualify under New Jersey’s expanded cannabis legislation – will benefit significantly from Curaleaf’s expansion.
Located at 640 Creek Road, the new Curaleaf dispensary was designed to improve patient access, reduce waiting times and enhance overall patient experience while providing a wide range of innovative cannabis products. Curaleaf’s nine dispensing stations, three spacious consult areas, multiple waiting rooms and dedicated conference and education spaces will contribute to making patients’ visits easier and more comfortable. Additionally, the spacious new dispensary enables Curaleaf to expand its operations while utilizing the existing, nearby cultivation facility. With this increased capacity, Curaleaf can better focus on serving the growing number of medical marijuana patients within Southern New Jersey through opportunities such as opening satellite locations, expanding cultivation and investing in education and outreach.
Totaling 6,150 square-feet in size, the new Bellmawr dispensary is the largest medical cannabis dispensary on the East Coast, as well as the largest under the Curaleaf brand. Photos of the Bellmawr location can be found here.
“Our expansion into a larger dispensary mirrors not only Curaleaf’s growth but also the progression of medical marijuana access within the state,” said George Schidlovsky, Curaleaf New Jersey’s president. “Providing patients safe access to high-quality medical cannabis has always been our driving force and seeing more people gain access to the care they need is rewarding for both Curaleaf and the greater Bellmawr community.”
Curaleaf is one of the largest medical cannabis dispensaries in the country, operating across multiple states. As a leading brand, Curaleaf prides itself on its customer service and premium products trusted by thousands of patients. To learn more about Curaleaf’s growing network of dispensaries visit www.curaleaf.com.
Led by a team of physicians, pharmacists, medical experts and industry visionaries, Curaleaf develops safe, effective, and innovative cannabis-based therapeutic products. Curaleaf combines the industry's most medically precise and technologically advanced production techniques in order to deliver consistent, high-quality products that patients and health care professionals can trust. Based on a foundation of compassion, professionalism and respect, Curaleaf strives to empower health care professionals and patients by providing product expertise and guidance to help them make the right choices. Curaleaf is committed to being the industry’s leading resource in education and advancement of medical cannabis through research and advocacy. Currently, Curaleaf manages multiple dispensaries across five states and its products are available in six states. More information regarding Curaleaf can be found at www.curaleaf.com.